Clinical Trial Update: Cisplatin, CPT-11 and Celecoxib With Radiation Therapy and Surgery for Operable Esophageal Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial assessing cisplatin, CPT-11, and celecoxib with radiation therapy and surgery in operable esophageal cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• CPT-11 (Irinotecan)
• Celecoxib (Celecoxib)

Snippet

Sponsor: Dana-Farber Cancer Institute | Conditions: Esophageal Cancer | Phase 2 | Status: COMPLETED